Aberdeen Group plc Sells 12,821 Shares of Stryker Corporation $SYK

Key Points

• Aberdeen Group plc trimmed its stake in Stryker by 4.2%, selling 12,821 shares and leaving it with 295,845 shares valued at about $103.98 million at quarter-end.
• Director Ronda E. Stryker sold 250,000 shares at an average price of $362.92 for roughly $90.73 million, a 9.23% reduction in her position; insiders now own about 5.90% of the company.
• Stryker beat quarterly estimates (EPS $4.47 vs. $4.40; revenue $7.17B, up 11.4% year-over-year) and announced a quarterly dividend of $0.88 ($3.52 annualized, ~1.1% yield) payable April 30.

Aberdeen Group plc cut its position in Stryker Corporation (NYSE:SYK - Free Report) by 4.2% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 295,845 shares of the medical technology company's stock after selling 12,821 shares during the quarter. Aberdeen Group plc owned about 0.08% of Stryker worth $103,981,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Czech National Bank increased its holdings in Stryker by 3.9% in the fourth quarter. Czech National Bank now owns 90,755 shares of the medical technology company's stock valued at $31,898,000 after purchasing an additional 3,366 shares during the period. Davis R M Inc. lifted its holdings in Stryker by 1.8% during the 3rd quarter. Davis R M Inc. now owns 138,732 shares of the medical technology company's stock worth $51,285,000 after buying an additional 2,512 shares during the period. Terra Alpha Investments LLC bought a new stake in shares of Stryker in the 3rd quarter valued at about $1,216,000. Kepler Cheuvreux Suisse SA bought a new stake in shares of Stryker in the 3rd quarter valued at about $27,952,000. Finally, Diversified Trust Co increased its stake in shares of Stryker by 45.6% in the third quarter. Diversified Trust Co now owns 12,445 shares of the medical technology company's stock valued at $4,601,000 after buying an additional 3,899 shares during the period. 77.09% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Stryker

In related news, Director Ronda E. Stryker sold 250,000 shares of the company's stock in a transaction on Wednesday, February 4th. The shares were sold at an average price of $362.92, for a total transaction of $90,730,000.00. Following the completion of the sale, the director directly owned 2,457,331 shares in the company, valued at $891,814,566.52. This represents a 9.23% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. 5.90% of the stock is currently owned by insiders.

Stryker Price Performance

SYK opened at $331.48 on Friday. The firm has a 50-day moving average price of $357.10 and a 200-day moving average price of $361.96. The company has a quick ratio of 1.21, a current ratio of 1.89 and a debt-to-equity ratio of 0.66. Stryker Corporation has a twelve month low of $319.32 and a twelve month high of $404.87. The company has a market capitalization of $126.95 billion, a price-to-earnings ratio of 39.46, a PEG ratio of 1.94 and a beta of 0.92.

Stryker (NYSE:SYK - Get Free Report) last announced its quarterly earnings results on Thursday, January 29th. The medical technology company reported $4.47 earnings per share for the quarter, beating the consensus estimate of $4.40 by $0.07. The firm had revenue of $7.17 billion for the quarter, compared to analysts' expectations of $7.12 billion. Stryker had a return on equity of 24.41% and a net margin of 12.92%.The company's revenue was up 11.4% on a year-over-year basis. During the same period in the prior year, the business posted $4.01 earnings per share. Equities analysts expect that Stryker Corporation will post 13.47 EPS for the current year.

Stryker Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, April 30th. Stockholders of record on Tuesday, March 31st will be paid a dividend of $0.88 per share. This represents a $3.52 dividend on an annualized basis and a dividend yield of 1.1%. The ex-dividend date of this dividend is Tuesday, March 31st. Stryker's dividend payout ratio is 41.90%.

Analysts Set New Price Targets

A number of equities analysts recently weighed in on SYK shares. Sanford C. Bernstein lifted their target price on shares of Stryker from $450.00 to $465.00 and gave the stock an "outperform" rating in a research note on Friday, January 9th. UBS Group cut their price target on shares of Stryker from $400.00 to $380.00 and set a "neutral" rating on the stock in a research report on Tuesday, March 17th. Robert W. Baird set a $437.00 price objective on Stryker in a research report on Friday, January 30th. The Goldman Sachs Group set a $399.00 target price on Stryker in a research note on Friday, January 9th. Finally, Piper Sandler reiterated an "overweight" rating on shares of Stryker in a report on Tuesday, January 27th. Fourteen equities research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $427.50.

Stryker Company Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons' offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.

Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Corporation (NYSE:SYK - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.